Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Perucca

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Neurology|January 8, 2025
Risk of Adverse Pregnancy Outcomes Associated With Antiseizure Medications and Their Indications: A Systematic Review and Meta-AnalysisAlexander Berry-Noronha, Pamada Manoleehakul, Alanna Rottler, et al.
Therapeutic Drug Monitoring|August 1, 2019
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug MonitoringValentina Franco, Katia Baruffi, Roberto Marchiselli, et al.
Epilepsia|August 22, 2012
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Trials|November 24, 2020
Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*)Bart van den Munckhof, Alexis Arzimanoglou, Emilio Perucca, et al.
European Journal of Neurology|November 6, 2021
Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation studyLevente Hadady, Péter Klivényi, Emilio Perucca, et al.
Epilepsy & Behavior : E&B|March 22, 2019
Seizure-alerting behavior in dogs owned by people experiencing seizuresAna Martos Martinez-Caja, Veerle De Herdt, Paul Boon, et al.
Epilepsy Research|July 28, 2012
The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control studyJason F Okulicz, Greg A Grandits, Jacqueline A French, et al.
Epilepsia|June 16, 2010
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsyMaria Paola Canevini, Giovambattista De Sarro, Carlo Andrea Galimberti, et al.
Epilepsia|November 6, 2009
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesPatrick Kwan, Alexis Arzimanoglou, Anne T Berg, et al.
Epilepsia|March 26, 2018
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307Gregory L Krauss, Emilio Perucca, Patrick Kwan, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Neurology|January 8, 2025
Risk of Adverse Pregnancy Outcomes Associated With Antiseizure Medications and Their Indications: A Systematic Review and Meta-AnalysisAlexander Berry-Noronha, Pamada Manoleehakul, Alanna Rottler, et al.
Therapeutic Drug Monitoring|August 1, 2019
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug MonitoringValentina Franco, Katia Baruffi, Roberto Marchiselli, et al.
Epilepsia|August 22, 2012
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Trials|November 24, 2020
Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*)Bart van den Munckhof, Alexis Arzimanoglou, Emilio Perucca, et al.
European Journal of Neurology|November 6, 2021
Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation studyLevente Hadady, Péter Klivényi, Emilio Perucca, et al.
Epilepsy & Behavior : E&B|March 22, 2019
Seizure-alerting behavior in dogs owned by people experiencing seizuresAna Martos Martinez-Caja, Veerle De Herdt, Paul Boon, et al.
Epilepsy Research|July 28, 2012
The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control studyJason F Okulicz, Greg A Grandits, Jacqueline A French, et al.
Epilepsia|June 16, 2010
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsyMaria Paola Canevini, Giovambattista De Sarro, Carlo Andrea Galimberti, et al.
Epilepsia|November 6, 2009
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesPatrick Kwan, Alexis Arzimanoglou, Anne T Berg, et al.
Epilepsia|March 26, 2018
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307Gregory L Krauss, Emilio Perucca, Patrick Kwan, et al.
Pageof 31